MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) is moving toward commercial deployment of its voice-based artificial intelligence platform for detecting drug and alcohol impairment, with initial applications targeting industrial safety in South America’s mining sector. The company recently appointed Chilean policy specialist Felipe Leyton to lead commercialization efforts in the region, signaling a transition from technology development to field implementation in large enterprise environments.
Leyton brings extensive experience in national drug policy and workplace safety. He helped design and implement Chile’s ‘Zero Tolerance’ alcohol-impaired driving law as part of the country’s alcohol prevention framework and played a role in establishing Chile’s roadside drug testing program introduced in 2019. His appointment reflects MindBio’s strategy of aligning technical development with regulatory and industry expertise in markets where impairment detection is closely tied to workplace safety and compliance requirements.
The AI prediction model uses over 50 million data points to predict alcohol intoxication with remarkable accuracy, just by using the human voice. The company is developing an enterprise platform including Edge-AI kiosks integrating bespoke hardware and software for the detection of drug and alcohol intoxication using the human voice and AI in a range of enterprise environments including the mining industry, aviation, construction and law enforcement.
The move toward commercial deployment in South America is significant given the region’s large mining operations, where impairment detection is critical for safety. Chile, in particular, has stringent workplace safety regulations and a history of zero-tolerance policies for alcohol impairment. MindBio’s technology could offer a non-invasive, rapid screening method that complements existing testing protocols.
For more details, the full article is available at https://ibn.fm/JBNVq. The latest news and updates relating to MBQIF are available in the company’s newsroom at https://ibn.fm/MBQIF.
MindBio is a biotechnology company commercializing AI prediction technologies for drug and alcohol intoxication detection via voice analysis. The implications of this announcement extend beyond the mining sector, as the platform could be adapted for aviation, construction, and law enforcement, potentially reducing workplace accidents and improving public safety.
